Respicardia Receives $10,000,006 Series D Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7a3659db-9065-4d14-b7d0-a5857608b499
Date
9/5/2013
Company Name
Respicardia
Mailing Address
12400 Whitewater Dr Minnetonka, MN 55343
Company Description
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.
Website
http://www.respicardia.com
Transaction Type
Venture Equity
Transaction Amount
$10,000,006
Transaction Round
Series D
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
M&A Terms
Venture Investor
Undisclosed